Safety and Efficacy of Trans Sodium Crocetinate (TSC) in Enhancing Tissue Oxygen Levels in Healthy Volunteers
Clinical trial NCT04808622 · COMPLETED
Trial details
- NCT number
- NCT04808622
- Sponsor
- Diffusion Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-17
- Primary completion
- 2021-03-21
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.